About
Based on years of research and trials at major medical institutions, Rebion is commercializing the breakthrough Neural Performance Scanning (NPS) to identify and help manage life-altering diseases that manifest from functional impairments in the brain. NPS portable point-of-care devices provide previously unavailable information for fast and impactful triage, making early disease detection, intervention and customized treatment more accessible.
Technologies
GmailGoogle AppsGoDaddy HostingGoogle PlayYouTubeGoogle Tag ManagerGoogle AnalyticsTypekitRemoteSisenseDomoKNIMEAI
Keywords
medical devicesopticsvision screeningamblyopiastrabismusmedical equipment manufacturingneurotechnologyfda-cleared vision scannervisual tracking impairmentsneuro-visual pathway evaluationhealthcare technologyearly intervention in eye diseasesstrabismus detectionfovea function analysisbiometric eye measurementretinal nerve fiber analysisearly disease detectionbrain-eye pathway assessmentneurodiagnostic toolsneural performance scanningportable point-of-care devicesmicro-strabismus detection devicefda cleared vision devicevision screening for pediatric populationsclinical trials in ophthalmologyneuro-ophthalmology toolsneurophysiological assessmenthealthcare equipment & suppliespediatric vision screeningophthalmology
Company Information
- Employees14
- Founded2009
- Total Funding$19516390
Location
100 Cambridge St, Boston, Massachusetts, United States, 02114
